Evonik – a CVC portfolio company – revealed in June that Colberg would be stepping down at the end of September following four years in the role at the Germany-headquartered company.
Bloomberg said Colberg would be working in CVC’s Frankfurt and Zurich offices.
Chemicals group Evonik became Germany’s biggest public listing in more than five years after its private equity owners revived plans for an IPO several months ago.
The listing, which was the biggest in the year to date, saw the business valued at €15.4bn.
CVC Capital and Germany’s RAG Foundation sold two per cent of the business through a pre-IPO placement in April which valued Evonik at almost €15bn.
That valuation of the company “significantly exceeded” the indicative prices for last year’s aborted IPO.
Copyright © 2013 AltAssets